229 related articles for article (PubMed ID: 10538332)
1. Cost of schizophrenia to UK Society. An incidence-based cost-of-illness model for the first 5 years following diagnosis.
Guest JF; Cookson RF
Pharmacoeconomics; 1999 Jun; 15(6):597-610. PubMed ID: 10538332
[TBL] [Abstract][Full Text] [Related]
2. Annual cost of erectile dysfunction to UK Society.
Plumb JM; Guest JF
Pharmacoeconomics; 1999 Dec; 16(6):699-709. PubMed ID: 10724796
[TBL] [Abstract][Full Text] [Related]
3. Cost of schizophrenia in England.
Mangalore R; Knapp M
J Ment Health Policy Econ; 2007 Mar; 10(1):23-41. PubMed ID: 17417045
[TBL] [Abstract][Full Text] [Related]
4. The excess cost of acute exacerbations of chronic bronchitis in patients aged 45 and older in England and Wales.
McGuire A; Irwin DE; Fenn P; Gray A; Anderson P; Lovering A; MacGowan A
Value Health; 2001; 4(5):370-5. PubMed ID: 11705127
[TBL] [Abstract][Full Text] [Related]
5. Annual cost of bipolar disorder to UK society.
Das Gupta R; Guest JF
Br J Psychiatry; 2002 Mar; 180():227-33. PubMed ID: 11872515
[TBL] [Abstract][Full Text] [Related]
6. A pharmacoeconomic evaluation of escitalopram versus citalopram in the treatment of severe depression in the United Kingdom.
Wade AG; Toumi I; Hemels ME
Clin Ther; 2005 Apr; 27(4):486-96. PubMed ID: 15922821
[TBL] [Abstract][Full Text] [Related]
7. Healthcare and wider societal implications of stillbirth: a population-based cost-of-illness study.
Campbell HE; Kurinczuk JJ; Heazell A; Leal J; Rivero-Arias O
BJOG; 2018 Jan; 125(2):108-117. PubMed ID: 29034559
[TBL] [Abstract][Full Text] [Related]
8. The annual societal cost of alcohol misuse in Scotland.
Varney SJ; Guest JF
Pharmacoeconomics; 2002; 20(13):891-907. PubMed ID: 12381241
[TBL] [Abstract][Full Text] [Related]
9. Cost analysis of palliative care for terminally ill cancer patients in the UK after switching from weak to strong opioids. Palliative Care Advisory Committee.
Guest JF; Hart WM; Cookson RF
Pharmacoeconomics; 1998 Sep; 14(3):285-97. PubMed ID: 10186467
[TBL] [Abstract][Full Text] [Related]
10. Cost of illness of inflammatory bowel disease in the UK: a single centre retrospective study.
Bassi A; Dodd S; Williamson P; Bodger K
Gut; 2004 Oct; 53(10):1471-8. PubMed ID: 15361497
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of levodopa/carbidopa/entacapone (Stalevo) compared to standard care in UK Parkinson's disease patients with wearing-off.
Findley LJ; Lees A; Apajasalo M; Pitkänen A; Turunen H
Curr Med Res Opin; 2005 Jul; 21(7):1005-14. PubMed ID: 16004667
[TBL] [Abstract][Full Text] [Related]
12. Costs of schizophrenia.
Knapp M
Br J Psychiatry; 1997 Dec; 171():509-18. PubMed ID: 9519088
[TBL] [Abstract][Full Text] [Related]
13. Economics and schizophrenia: the real cost.
Davies LM; Drummond MF
Br J Psychiatry Suppl; 1994 Nov; (25):18-21. PubMed ID: 7865193
[TBL] [Abstract][Full Text] [Related]
14. The economic consequences of prostate and bladder cancer in the UK.
Sangar VK; Ragavan N; Matanhelia SS; Watson MW; Blades RA
BJU Int; 2005 Jan; 95(1):59-63. PubMed ID: 15638895
[TBL] [Abstract][Full Text] [Related]
15. The cost of epilepsy in the United Kingdom: an estimation based on the results of two population-based studies.
Cockerell OC; Hart YM; Sander JW; Shorvon SD
Epilepsy Res; 1994 Jul; 18(3):249-60. PubMed ID: 7805646
[TBL] [Abstract][Full Text] [Related]
16. Cost of illness associated with Niemann-Pick disease type C in the UK.
Imrie J; Galani C; Gairy K; Lock K; Hunsche E
J Med Econ; 2009 Sep; 12(3):219-29. PubMed ID: 19725798
[TBL] [Abstract][Full Text] [Related]
17. [Comparison of medical and economic benefits of antipsychotics in the treatment of schizophrenia in France].
Druais S; Doutriaux A; Cognet M; Godet A; Lançon C; Levy P; Samalin L; Guillon P
Encephale; 2017 Aug; 43(4):311-320. PubMed ID: 27623123
[TBL] [Abstract][Full Text] [Related]
18. Economic burden of schizophrenia: empirical analyses from a survey in Thailand.
Phanthunane P; Whiteford H; Vos T; Bertram M
J Ment Health Policy Econ; 2012 Mar; 15(1):25-32. PubMed ID: 22611090
[TBL] [Abstract][Full Text] [Related]
19. Use and cost of hospital and community service provision for children with HIV infection at an English HIV referral centre.
Beck EJ; Mandalia S; Griffith R; Beecham J; Walters MD; Boulton M; Miller DL
Pharmacoeconomics; 2000 Jan; 17(1):53-69. PubMed ID: 10747765
[TBL] [Abstract][Full Text] [Related]
20. Modelling the treated course of schizophrenia: development of a discrete event simulation model.
Heeg B; Buskens E; Knapp M; van Aalst G; Dries PJ; de Haan L; van Hout BA
Pharmacoeconomics; 2005; 23 Suppl 1():17-33. PubMed ID: 16416759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
